Advancements in Biotechnology and Medical Imaging Technologies
Update: 2025-10-21
Description
Oragenics Inc. has regained compliance with NYSE American's listing standards after a successful public offering, focusing on advancing brain-targeted therapeutics. Researchers are developing nanoparticles to combat scarring in alcohol-related liver disease, with implications for other organs. Investors are interested in next-generation 3D AI-imaging technologies, particularly for breast cancer detection, with companies like Izotropic Corporation leading the way. Oncotelic Therapeutics Inc. has initiated Phase 1 trials for Sapu003, a nanoparticle formulation enhancing breast cancer drug delivery.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
